We've started seeing more articles related to the topic of Twitter and the corporate world of Pharma/Biotech. Pharmavoice recently published an article titled, "What is the business case for Tweeting?" (to read the article,
click here)
Is Twitter simply a cocktail party where you can mingle and exchange information with others? Or, is Twitter much more than that?
According to this article, 18 pharma companies were using Twitter as of last month. J&J (Johnson and Johnson) appears to be the most active, but you'll also see other large pharma companies such as: AstraZeneca, Novartis, GSK, Pfizer, Roche, Boehringer Ingelheim, Novo Nordisk, and several others.
So while we're on this topic of Twitter, let me throw out a few questions:
- Is Twitter simply another marketing tool in this new wave of social media?
- Will the FDA regulate how pharma uses Twitter to communicate with consumers and healthcare professionals?
- Is Twitter an effective way to communicate safety issues to healthcare professionals? (the FDA and CDC are using Twitter)
- Is Twitter a way for consumers to send messages directly to Pharma?
- Is Twitter a temporary fad, or is it here to stay?
I encourage you to explore social media and try using Twitter for a few weeks. You won't be impressed if you only try it for a few days. However, give it a few months and see what you think. You have to be willing to follow some people back and exchange ideas (imagine that you're at a social event).
You can start by following my Tweets here:
http://twitter.com/DrJosephKim
If you're interested in an alternative physician career in the biopharma industry, then I would encourage you to read Pharmaceutical Executive Magazine. This magazine will help you stay current on business issues that affect the pharmaceutical industry. This month's cover story features Deirdre Connelly (President, North American Pharmaceuticals for GlaxoSmithKline) as HBA's 2010 Woman of the Year. 
